Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qidong Dongyue Pharmaceutical is a specialized pharmaceutical company based in Qidong, China, focused on the development and large-scale production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Established in 1990, the company has become a significant global supplier of H2-receptor antagonists, including Famotidine and Nizatidine. Their manufacturing facilities are operated under strict GMP standards, serving both domestic and international markets in the gastrointestinal and cardiovascular sectors. In addition to its own product catalog, the company provides contract manufacturing (CMO) services for small molecule synthesis to global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qidong Dongyue Pharmaceutical.